News

TherOx Inc. announced the initiation of its multicenter Investigational Device Exemption (IDE) pilot study of a second generation system that delivers supersaturated oxygen (SSO2) therapy for reduction of infarct size after an AMI. SSO2 therapy is intended to provide interventional cardiologists with the first treatment option beyond percutaneous coronary intervention (PCI) to salvage heart muscle in heart attack patients.

Home March 20, 2013
Home
News

Northwest Community Healthcare (NCH) is unveiling new imaging and lab results functionality for its mobile app, MyNCH, which allows NCH Medical Group patients to view their lab and imaging results with just the tap of a finger on their smartphone.

Home March 20, 2013
Home
Videos | Cath Lab

Ajay Kirtane, M.D., SD, chief academic officer at Columbia University Medical Center/New York Presbyterian Hospital ...

Home March 19, 2013
Home
Videos | ACC

The American College of Cardiology (ACC) 2013 Scientific Session Committee Chairman Miguel Quinones, M.D., explains some ...

Home March 19, 2013
Home
Videos | ACC

DAIC Editor Dave Fornell explains his choices for the most innovative new technology on the expo floor at the American ...

Home March 19, 2013
Home
Edwards Sapien, PARTNER, 3 year followup
Feature

The three-year results of a pivotal clinical study comparing the Edwards Sapien transcatheter heart valve and open-heart surgery demonstrated comparable outcomes. These new data from The PARTNER Trial were presented today as a late-breaking clinical trial at the American College of Cardiology's (ACC) 62nd Annual Scientific Session in San Francisco.

Home March 19, 2013
Home
Technology

Spacelabs Healthcare has released the latest version of their cardiology information management system — Sentinel v.9 — with a new seamlessly integrated ABP module.

Home March 19, 2013
Home
Technology

Terumo Interventional Systems expanded its family of Heartrail III Coronary Guiding Catheters to include a smaller profile 5 French Ikari shape, specifically designed to provide backup support and access to target coronary lesions during transradial catheterizations. The smaller 5 French Heartrail is designed to help physicians achieve access to the coronary arteries using a smaller-diameter catheter platform, and proprietary Ikari tip shapes, while providing the backup support and body of a traditionally larger French size catheter.

Home March 19, 2013
Home
News

Alere Inc. announced the results of research presented at the American College of Cardiology’s 62nd Annual Scientific Session, which showed that a simple screening and management program can be effective in preventing heart failure for at-risk patients.

Home March 19, 2013
Home
ekos, pulmonary embolism, clot busting
Feature

Results of the ULTIMA trial using endovascular therapy to treat submassive pulmonary embolism (PE) were presented at the American College of Cardiology 2013 meeting, The trial is the first randomized controlled trial comparing the use of an endovascular approach along with anticoagulation vs. anticoagulation therapy alone, the current standard of care.

Home March 19, 2013
Home
Edward Structural Heart Valve Repair Clinical Trial Sapien XT Transcatheter
Feature

Edwards Lifesciences Corporation announced that preliminary results from The PARTNER II Trial demonstrated similar one-year outcomes in mortality and major clinical events between the Edwards Sapien XT transcatheter aortic valve and the Edwards SAPIEN valve, yet fewer vascular events with the lower-profile Sapien XT valve. These data from The PARTNER II Trial studying transcatheter aortic valve replacement (TAVR) in inoperable patients with severe, symptomatic aortic stenosis were presented as a late-breaking clinical trial at the American College of Cardiology's (ACC) 62nd Annual Scientific Session in San Francisco.

Home March 19, 2013
Home
Boston Scientific Watchmen Left Atrial Appendage Closure Atrial Fibrillation
Feature

Boston Scientific reports preliminary data in the PREVAIL clinical trial met two out of three co-primary endpoints. The data was supposed to be presented during the 2013 American College of Cardiology (ACC) meeting on March 9 as the lead-off late breaking trial. However, Boston Scientifc released information about the trial prior to ACC lifting the embargo. As a result of the embargo break, the presentation was pulled off the ACC agenda.

Home March 19, 2013
Home
News

Medtronic Inc. announced it has received CE mark and will begin the European launch of the Attain Performa portfolio of quadripolar leads.

Home March 18, 2013
Home
Technology

At the American College of Cardiology (ACC) conference, GE Healthcare unveiled DoseMap to alert interventional cardiologists to patient radiation exposure during longer procedures.

Home March 18, 2013
Home
Accumetrics Verify Now ACC 2013 Antiplatelet Therapy Blood Testing Pharmaceutica
Feature

Accumetrics Inc. announced the presentation of a series of important data that solidifies the clinical utility of platelet reactivity testing. Real world outcomes data in high-risk patients receiving stents, a cost effectiveness analysis, and validation of a therapeutic window continue to demonstrate platelet reactivity as a critical element for improving the quality of care for the millions of patients on antiplatelet therapies worldwide.

Home March 18, 2013
Home
Subscribe Now